Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gorana Capkun

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Comparative Effectiveness Research|July 1, 2024
The value of evidence and its role in driving product strategyMelvin Skip Olson, Gorana Capkun
Clinical Pharmacology and Therapeutics|March 11, 2025
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real-World EvidenceGorana Capkun, Melvin Skip Olson
Pest Management Science|September 18, 2002
Natural variation in baseline data: when do we call a new sample 'resistant'?Lukas Schaub, Sylvain Sardy, Gorana Capkun
International Journal of Epidemiology|May 17, 2005
Trends in primary care consultations for asthma in Switzerland, 1989-2002Ueli Bollag, Gorana Capkun, Julius Caesar, et al.
Current Medical Research and Opinion|September 30, 2014
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27Richard Nixon, Gorana Capkun-Niggli, Niklas Bergvall, et al.
American Health & Drug Benefits|July 4, 2014
The economic burden of fragile x syndrome: healthcare resource utilization in the United StatesPatricia Sacco, Gorana Capkun-Niggli, Xin Zhang, et al.
Journal of Neuromuscular Diseases|May 17, 2017
A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body MyositisAoife Callan, Gorana Capkun, Vijayalakshmi Vasanthaprasad, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Journal of Comparative Effectiveness Research|June 14, 2022
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USAKayla Engelbrecht, Srinjoy Roy, Gorana Capkun, et al.
BMC Medical Research Methodology|December 24, 2014
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusionHoward H Z Thom, Gorana Capkun, Richard M Nixon, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Comparative Effectiveness Research|July 1, 2024
The value of evidence and its role in driving product strategyMelvin Skip Olson, Gorana Capkun
Clinical Pharmacology and Therapeutics|March 11, 2025
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real-World EvidenceGorana Capkun, Melvin Skip Olson
Pest Management Science|September 18, 2002
Natural variation in baseline data: when do we call a new sample 'resistant'?Lukas Schaub, Sylvain Sardy, Gorana Capkun
International Journal of Epidemiology|May 17, 2005
Trends in primary care consultations for asthma in Switzerland, 1989-2002Ueli Bollag, Gorana Capkun, Julius Caesar, et al.
Current Medical Research and Opinion|September 30, 2014
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27Richard Nixon, Gorana Capkun-Niggli, Niklas Bergvall, et al.
American Health & Drug Benefits|July 4, 2014
The economic burden of fragile x syndrome: healthcare resource utilization in the United StatesPatricia Sacco, Gorana Capkun-Niggli, Xin Zhang, et al.
Journal of Neuromuscular Diseases|May 17, 2017
A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body MyositisAoife Callan, Gorana Capkun, Vijayalakshmi Vasanthaprasad, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Journal of Comparative Effectiveness Research|June 14, 2022
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USAKayla Engelbrecht, Srinjoy Roy, Gorana Capkun, et al.
BMC Medical Research Methodology|December 24, 2014
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusionHoward H Z Thom, Gorana Capkun, Richard M Nixon, et al.
Pageof 4